Table of contents:
Video: A Successful Migraine Treatment Thanks To The Specific Drug Aimovig
Intense and recurring headache, nausea, vomiting … migraine is an extremely unpleasant condition that disrupts the daily lives of 11 million people with a predominance of women. Many Internet sources offer different methods of relieving a migraine, but this is usually a temporary effect and not very effective. However, a new migraine treatment drug promises to give patients hope so they can return to normal life. So, is there really light at the end of the tunnel?
The first drug for migraine treatment: what we know
Although in July 2018 the European Union gave the green light to the marketing of the first drug intended for the treatment of migraine, the article is not yet marketed in France. More specifically, this is the specific drug Aimovig, whose composition based on monoclonal anti-CGPR antibodies is proving very good news for patients suffering from migraine attacks. The treatment requires an injection once a month and costs around 600-1000 euros (per injection) abroad.
More concretely, the injection represents a pen filled with a solution to inject oneself. It is intended for people who suffer from at least four migraine attacks per month and who have already tried two other treatments without success. 40% of patients who have already treated their migraine with Aimovig report a considerable reduction in monthly seizures, according to clinical trials.
Moreover, a 48-year-old Frenchwoman recently told Le Monde about the beneficial effects of the treatment in question. She managed to take advantage of it thanks to a compassionate protocol lasting one year. Before resorting to it, Stéphanie tested all the available treatments but unfortunately the results did not last. What is more, she suffered from the often painful side effects as well as a burnout followed by depression. Not to mention the frequent emergency room visits due to analgesic infusions.
Stephanie started getting Aimovig injected last June and saw almost immediate results. She even managed to get rid of the hypersensitivity of the skull which continued to persist after the seizure passed.
Being for the moment unavailable in France, this revolutionary migraine treatment is the only hope for people affected by these painful crises preventing their normal life. It has become clear, moreover, that negotiations on the price of the injections are still ongoing so we look forward to good news in the future.